From: Role of bile acids in the prediction of hepatocellular carcinoma in HCV-induced liver cirrhosis
BA | NHC | NCLD | CLD | HCC | F, NCLD | F, CLD | F, HCC |
---|---|---|---|---|---|---|---|
CA | 0.20 ± 0.3 | 0.6 ± 1.7 NS | 0.5 ± 0.86* | 1.7 ± 4* | 3* | 3* | 9* |
CDCA | 0.38 ± 0.51 | 0.73 ± 1.2 NS | 1.45 ± 1.91* | 5.1 ± 14* | 2* | 4* | 13* |
DCA | 0.15 ± 0.16 | 0.19 ± 0.11* | 0.31 ± 0.40 NS | 0.25 ± 0.39 NS | 1 | 2* | 2* |
LCA | 0.01 ± 0.03 | 0.03 ± 0.05* | 0.05 ± 0.09* | 0.11 ± 0.20* | 3* | 4* | 9* |
UDCA | 0.04 ± 0.1 | 0.04 ± 0.08 NS | 1.56 ± 5.01* | 1.99 ± 6* | 1 | 38* | 48* |
GCA | 0.24 ± 0.33 | 0.43 ± 0.77 NS | 3.77 ± 4.06* | 8.4 ± 13* | 2* | 16* | 35* |
GCDCA | 0.45 ± 0.66 | 0.86 ± 1.04* | 7.7 ± 11.5* | 12.5 ± 17* | 2* | 17* | 29* |
GDCA | 0.24 ± 0.36 | 0.26 ± 0.33 NS | 1.48 ± 2.9* | 1.72 ± 7.2 NS | 1 | 6* | 7* |
GUDCA | 0.15 ± 0.2 | 0.07 ± 0.12* | 5.2 ± 12.9* | 9.4 ± 30* | 0.5 | 35* | 38* |
TCA | 0.01 ± 0.05 | 0.04 ± 0.09* | 1.7 ± 2.7* | 7.05 ± 16* | 3* | 113* | 473* |
TCDCA | 0.11 ± 0.18 | 0.07 ± 0.15 NS | 4.77 ± 13.8* | 9.1 ± 16* | 0.7 | 44* | 83* |
TDCA | 0.07 ± 0.15 | 0.02 ± 0.03 NS | 0.19 ± 0.36 NS | 1.6 ± 6 NS | 0.3 | 3* | 24* |
TLCA | 0.006 ± 0.028 | 0.001 ± 0.002* | 0.02 ± 0.07* | 0.08 ± 0.3* | 0.3 | 4* | 13* |
TUDCA | 0.04 ± 0.12 | 0.01 ± 0.02NS | 0.09 ± 0.37 NS | 0.90 ± 5.17 NS | 0.3 | 2* | 18* |